Tecon Biology shareholders approve key resolutions at meeting

At the extraordinary general meeting held on March 24, 2025, Tecon Biology (SZSE:002100) shareholders approved several key resolutions. These included a resolution to engage in commodity futures hedging, with 98.75% of attending shareholders voting in favor. A resolution for debt financing of up to a total of RMB million was also approved by 98.77% of shareholders. In addition, Shareholders voted with a 98.68% majority to approve providing guarantees for raw material procurement for subsidiaries. Finally, shareholders voted on the termination of some fundraising and voted to allocate those funds to other purposes.